Sep 26, 2019, 14:00 ET
TORONTO, Sept. 26, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced that CEO Kim Rivers is scheduled to deliver a keynote address at Arcview Investor Forum: The Evolution of Cannabis: 2020, on Wednesday, October 2nd, 2019. This three-day event being held in New York City will bring together top fund managers and key investors with prominent leaders from the cannabis industry.
Ms. Rivers' presentation will commence at 5:15 p.m. EDT and focus on diversity and inclusion and the positive socio-economic impacts these initiatives could have on the industry. As CEO of Trulieve, Ms. Rivers is an avid supporter of diversity initiatives, having received the 2018 Diversity and Inclusion Champion of the Year Award from Minorities for Medical Marijuana.
In addition to her Arcview Investor Forum presentation, Ms. Rivers is scheduled to present at the Canaccord US Cannabis Symposium on October 3rd in Toronto. Also on October 3rd, Jason Pernell, Trulieve's Chief Information Officer, will be at the AGP Consumer Cannabis Conference in New York City.
Following these events, the presentations will be made available on the Trulieve Investor Relations website at https://investors.trulieve.com/events-presentations.
Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
SOURCE Trulieve Cannabis Corp.
For further information: Lynn Ricci, Director of Investor Relations, 1-850-270-5691, [email protected]
Share this article